CN1582336A - 粘膜炎莫拉氏菌(布兰汉氏菌属)抗原 - Google Patents

粘膜炎莫拉氏菌(布兰汉氏菌属)抗原 Download PDF

Info

Publication number
CN1582336A
CN1582336A CNA02812216XA CN02812216A CN1582336A CN 1582336 A CN1582336 A CN 1582336A CN A02812216X A CNA02812216X A CN A02812216XA CN 02812216 A CN02812216 A CN 02812216A CN 1582336 A CN1582336 A CN 1582336A
Authority
CN
China
Prior art keywords
polypeptide
seq
polynucleotide
sequence
sequence selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA02812216XA
Other languages
English (en)
Chinese (zh)
Inventor
D·马丁
J·哈枚尔
B·R·布罗德尔
S·利欧克斯
G·莱布兰克
J·科特尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID Biomedical Corp of Washington
Original Assignee
Shire BioChem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire BioChem Inc filed Critical Shire BioChem Inc
Publication of CN1582336A publication Critical patent/CN1582336A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Otolaryngology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CNA02812216XA 2001-06-18 2002-06-18 粘膜炎莫拉氏菌(布兰汉氏菌属)抗原 Pending CN1582336A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29840301P 2001-06-18 2001-06-18
US60/298,403 2001-06-18
US33009501P 2001-10-19 2001-10-19
US60/330,095 2001-10-19

Publications (1)

Publication Number Publication Date
CN1582336A true CN1582336A (zh) 2005-02-16

Family

ID=26970641

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA02812216XA Pending CN1582336A (zh) 2001-06-18 2002-06-18 粘膜炎莫拉氏菌(布兰汉氏菌属)抗原

Country Status (8)

Country Link
US (1) US20050080233A1 (enExample)
EP (2) EP1399563B1 (enExample)
JP (1) JP2005508146A (enExample)
CN (1) CN1582336A (enExample)
AT (1) ATE421586T1 (enExample)
CA (1) CA2455254A1 (enExample)
DE (1) DE60230984D1 (enExample)
WO (1) WO2002102836A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110540594A (zh) * 2018-12-20 2019-12-06 湖北工业大学 基于卡他莫拉菌表面蛋白的乳胶微球免疫层析试纸的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
GB9817824D0 (en) * 1998-08-14 1998-10-14 Smithkline Beecham Biolog Novel compounds
AU1824101A (en) * 1999-06-18 2001-01-09 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110540594A (zh) * 2018-12-20 2019-12-06 湖北工业大学 基于卡他莫拉菌表面蛋白的乳胶微球免疫层析试纸的制备方法

Also Published As

Publication number Publication date
DE60230984D1 (de) 2009-03-12
EP2166096A2 (en) 2010-03-24
CA2455254A1 (en) 2002-12-27
WO2002102836A3 (en) 2003-05-22
EP1399563A2 (en) 2004-03-24
EP1399563B1 (en) 2009-01-21
EP2166096A3 (en) 2010-06-09
JP2005508146A (ja) 2005-03-31
ATE421586T1 (de) 2009-02-15
US20050080233A1 (en) 2005-04-14
WO2002102836A2 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
CN1191362C (zh) 新颖的链球菌抗原
CN1268745C (zh) B组链球菌抗原
CN1159441C (zh) 粘膜炎莫拉菌的uspa1和uspa2抗原
CN1222618C (zh) 卡他摩拉克菌外膜蛋白－106多肽及其基因序列和用途
CN1201818C (zh) 疫苗
CN1449446A (zh) 链球菌抗原
CN101031584A (zh) 脑膜炎球菌蛋白nmb1870的结构域和表位
CN1556857A (zh) 呼吸道合胞病毒(rsv)g蛋白的新肽及其在疫苗中的应用
CN1203180C (zh) 来自脑膜炎奈瑟氏球菌的basb006多核苷酸和多肽
CN1298848C (zh) 具有减弱的蛋白酶活性的嗜血杆菌Hin47类似物
CN1414018A (zh) 间日疟原虫和镰状疟原虫红细胞结合蛋白的结合区
CN1245512C (zh) 含重组菌毛蛋白的抗淋病奈瑟氏球茵或脑膜炎奈瑟氏球菌的疫苗
CN1204253C (zh) 奈瑟氏球菌乳铁蛋白结合蛋白
CN1198918C (zh) 减毒的活胸膜肺炎放线杆菌
CN1653084A (zh) 酶活性减少的非典型流感嗜血杆菌的p4蛋白突变体
CN1531548A (zh) 编码可诱导抗病毒效应的蛋白质的嵌合链
CN1210401C (zh) 源自粘膜炎莫拉氏菌的化合物
CN101063141A (zh) 粘膜炎莫拉氏菌(布兰汉氏菌)抗原
CN1629188A (zh) 日本血吸虫的特异性抗原及用途
CN1582336A (zh) 粘膜炎莫拉氏菌(布兰汉氏菌属)抗原
CN1549727A (zh) 粘膜炎莫拉氏(布拉汉氏)菌多肽及相应dna片段
CN1603346A (zh) 蛋白质，含有其的产品及其在诊断、治疗和/或预防sars相关疾病中的用途
HK1110625A (en) Moraxella(branhamella) catarrhalis antigens
CN1545552A (zh) 基因和蛋白质及它们的用途
CN1375006A (zh) 新型化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: YIDE BIOLOGICAL MEDICAL CO.,LTD.

Free format text: FORMER OWNER: SHIRE BIOCHEM INC.

Effective date: 20050715

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20050715

Address after: British Columbia

Applicant after: Id Biomedical

Address before: Quebec

Applicant before: Shire Biochem Inc.

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20050216